Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients

Value in Health

Volumn 10, Issue 5, 2007, Pages 408-414

  Wu, Eric Q ^a   Mulani, Parvez ^b   Farrell, Max H ^a   Sleep, Darryl ^b  

^a ANALYSIS GROUP   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

EORTC QLQ C30; EQ 5D; FACT P; Preference adjusted health status; Quality of life

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CANCER PATIENT; COST UTILITY ANALYSIS; DEMOGRAPHY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SCORING SYSTEM; STATISTICAL MODEL; STRUCTURED QUESTIONNAIRE;

EID: 34748912350     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00195.x     Document Type: Article

References (24)

1. National Cancer Institute. DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, Surveillance, Epidemiology, and End Results (SEER) Program. Prevalence database: "US Estimated 28-Year L-D Prevalence Counts on 1/1/2003 by Duration." Released April 2006, based on the November 2005 SEER data submission.
2. National Cancer Institute. DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, Surveillance, Epidemiology, and End Results (SEER) Program. Prevalence database: "US Estimated Complete Prevalence Counts on 1/1/2003." Released April 2006, based on the November 2005 SEER data submission.
3. Oh W, Kantoff P. Management of hormone refractory prostate cancer: current standards and future prospects. J Urol 1998 160 : 1220 9.
4. Hanks GE, Myers CE, Scardino PT. Cancer of the prostate. In : DeVita VT Jr., Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia, PA : Lippincott, 1993.
5. Ries LAG, Harkins D, Krapcho M, et al., eds. SEER Cancer Statistics Review. Bethesda, MD : National Cancer Institute, 1975-2003. Available from: http://seer.cancer.gov/csr/1975_2003/ [Accessed October 30, 2006]. Based on November 2005 SEER data submission, posted to the SEER website, 2006.
6. Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 2001 21 : 105 12.
7. Sengupta N, Nichol MB, Wu J, et al. Mapping the SF-12 to the HUI3 and VAS in a managed care population. Med Care 2004 42 : 927 37.
8. Fryback DG, Lawrence WF, Martin PA, et al. Predicting quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997 17 : 1 9.
9. Franks P, Lubetkin E, Gold M, et al. Mapping the SF-12 to the EuroQol EQ-5D index in a national U.S. sample. Med Decis Making 2004 24 : 247 54.
10. Gray AM, Rivero-Arias O, Clarke PM. Estimating the association between SF-12 response and EQ-5D utility values by response mapping. Med Decis Making 2006 26 : 18 29.
11. Shaw J, Johnson J, Coons S. US Valuation of the EQ-5D health states development and testing of the D1 valuation model. Med Care 2005 43 : 203 20.
12. Cella D, Tulsky D, Gray G, et al. The Functional Assessment of Cancer Therapy (FACT) scale: development and validation of the general measure. J Clin Oncol 1993 11 : 570 9.
13. Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997 50 : 920 8.
14. Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 85 : 365 76.
15. Fishman M, Jacobsen P, Chen N, et al. Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer. J Clin Oncol 2005 ASCO Annual Meeting Proceedings 2005 23 : 8106.
16. Greene WH. Econometric Analysis (4th ed.). Upper Saddle River, NJ : Prentice Hall, 2000.
17. Rousseeuw PJ. Least median of squares regression. J Am Stat Assoc 1984 79 : 871 80.
18. Austin PC. A comparison of methods for analyzing health-related quality of life measures. Value Health 2002 5 : 329 37.
19. Daley J, Jencks S, Draper D, et al. Predicting hospital-associated mortality for Medicare patients: a method for patients with stroke, pneumonia, acute myocardial infarction, and Congestive heart failure. JAMA 1988 260 : 3617 24.
20. Keeler EB, Kahn KL, Draper D, et al. Changes in sickness at admission following the introduction of the prospective payment system. JAMA 1990 264 : 1962 8.
21. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 100 : 1619 36.
22. Naessens JM, Leibson CL, Krishan I, et al. Contribution of a measure of disease complexity (COMPLEX) to prediction of outcome and charges among hospitalized patients. Mayo Clin Proc 1992 67 : 1140 9.
23. Lezzoni LI. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, MI : Health Administration Press, 1994.
24. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998 316 : 736 41.